Verily

1y

Fitfully named the care team, Verily clinical experts are at the very heart of our virtual diabetes management programs. This deep bench of health coaches and licensed clinicians includes Dr. Neeli Singh, MD, endocrinologist and Onduo P.C. Medical Director. Dr. Singh connects with members and guides them through tailored paths to better manage their diabetes, which can help protect their cardiovascular health, too. Discover Dr. Singh’s love for her patients and providing precision care.

Verily

1y

Veeps across Verily offices celebrated the year of the snake with lots of food and well wishes for health, happiness, and good fortune. #LunarNewYear

Verily

1y

Erich Huang, Verily’s Associate Chief Clinical Officer, Informatics & Technology, is headed to ViVE next week in Nashville. As an expert in AI and reinforcement learning to drive precision health, he’ll participate in two panels: ➡️ I Will Not Walk 500 Miles for Equitable Access to Medicine on February 17 at 2:25 PM CT Dr. Huang will join copanelists Dr. Nwando Anyaoku, MD, MPH, MBA, Lakshmi Halasyamani, Sid Viswanathan, and moderator Elana Berkowitz to discuss new approaches to equitable access to medications that prioritize accessibility and affordability. ➡️ Advancing Dermatology Through Digital Innovation on February 18 at 2:00 PM CT This invite-only session hosted by Takeda will explore how technology is transforming dermatology care.

Verily

1y

With respiratory viruses spreading across the country, wastewater testing is being used to help identify which viruses are surging. Amy Lockwood, Verily Public Health Partnerships Lead, spoke to WRTV about Verily's role in wastewater testing for community pathogen tracking, discussing the testing process and our partnerships.

Verily

1y

The Verily team was at SCOPE this week, collaborating with leaders from sites, sponsors and CROs on strategies to improve clinical research. Yugang Jia, Ph.D MPH and Lauren Sutton gave a talk on our progress using AI and LLMs to digitize clinical trial protocols. They spoke about the potential for digital protocols to serve as a blueprint for systems across the clinical operations technology ecosystem.

Verily

1y

❤️ Today on #WearRedDay, we share the importance of heart failure (HF) education and support interventions for women to improve HF prevention strategies and medication management. Read recent study results based on data from participants of the American Heart Association's Research Goes Red registry, powered by Verily.

Verily

1y

2025 will be an exciting year for Verily as we bring new products to market that realize our precision health vision. Through the Verily platform, we can: ✳️ Help customers activate their data directly in care environments and research workflows ✳️ Provide access to a unique data ecosystem to enrich and enhance customer data ✳️ Use AI to help automate tasks, scale expertise, and to turn data to insight In the blog, Verily in ’25 and beyond, our CEO Stephen Gillett details how our solutions provide the data and tech to unlock the promise of AI and data science to improve healthcare.

Verily

1y

Discover the future of protocol management with Verily's patented, AI- driven technology. This introduction to protocol digitization explores how automation enhances accuracy and efficiency across industries.

Verily

1y

How will AI impact the biopharma industry in 2025? Verily Chief Medical and Scientific Officer Andrew Trister shared his predictions about how AI will be applied to data and to clinician decision-making with Citeline SCRIP.

Verily

1y

Clinical trial protocols are long, static documents, requiring sponsors to manually configure data across many systems, leading to inefficiencies and extended timelines. The use of AI/LLM agents to digitize protocols optimizes research for sponsors and sites. Verily’s Lauren Sutton and Yugang Jia explain how at SCOPE on Tuesday, February 6th at 11:55 AM ET.